Skip to content

PanACEA

  • Contact us
  • Twitter
  • News
  • About Us
    • Mission
    • History
    • Governance
    • Donors
    • Scientific Network
  • Tuberculosis
    • Impact
    • Treatment
    • Drug development
  • Clinical Studies
    • Trial Design
    • PanACEA Studies
    • Vision for future Studies
  • Capacity Development

ACRO

Posted on May 17, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

Post navigation

← Accelerating the pathway from drug discovery to patient treatment – pioneering advanced development methodologies for new TB drug regimens
Clinical →

Recent Posts

  • Dr Jodie Schildkraut
  • Dr. Laura Paramo MD
  • Staggered dosing of rifampicin using to minimise tolerability problems and maximize efficacy
  • SUDOCU headline results presented at CROI
  • Ivan Noreña MD, MSc.
© PanACEA
  • edctp
  • European Union

  • This project is part of the
    EDCTP2 programme supported
    by the European Union

  • Contact us
  • Twitter